Background: Drug provocation test (DPT) represents the gold standard for the diagnosis of drug allergy. A DPT can be performed in a single-blind placebo-controlled manner. In anxiety and depressive disorders, patients need to be evaluated to understand the nature of placebo reactions. Objective: The aim of this study was to evaluate the psychological profile of patients with reactions to placebo during a DPT. Methods: We consecutively enrolled patients with suspected drug allergy undergoing a DPT preceded by the administration of the placebo. All patients underwent the Hospital Anxiety and Depression Scale (HADS), a questionnaire aimed to identify anxiety and depression, before the challenge test. Results: A total of 196 patients were enrolled into this study: 8 (4%) patients resulted positive to the DPT, 60 (30.6%) demonstrated anxiety or depression based on the HADS, and 54 had at least 1 placebo reaction during drug provocation. There were statically significant correlations between the positivity of the HADS and the finding of a placebo reaction (Fisher's exact test: P <.001), and between the latter and a history of severe reactions to drug (Fisher's exact test: P <.001). Conclusions: There is a significant and strong correlation between the loss of psychic equilibrium and the development of a placebo reaction during a DPT. We suggest the use the HADS or other validated questionnaire in clinical practice before a DPT to evaluate the possible psychiatric components.
|Number of pages||5|
|Journal||Journal of Allergy and Clinical Immunology: In Practice|
|Publication status||Published - Sep 1 2018|
- Drug allergy
- Drug provocation test
ASJC Scopus subject areas
- Immunology and Allergy